BNP Paribas Financial Markets
DRUG

BNP Paribas Financial Markets’s Bright Minds Biosciences DRUG Stock Holding History

BNP Paribas Financial Markets’s Portfolio DRUG Stock Details DRUG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$115K Sell
1,571
-24,105
-94% -$1.94M ﹤0.01% 4306
2025
Q4 		$2M Buy
25,676
+20,880
+435% +$1.4M ﹤0.01% 2613
2025
Q3 		$291K Buy
4,796
+4,339
+949% +$168K ﹤0.01% 3833
2025
Q2 		$11.9K Sell
457
-643
-58% -$19.3K ﹤0.01% 4802
2025
Q1 		$39.7K Buy
+1,100
New +$40.3K ﹤0.01% 4365

Other funds holding DRUG

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return

BNP Paribas Financial Markets's DRUG Position: Q1 2026 in Review

BNP Paribas Financial Markets reduced its Bright Minds Biosciences (DRUG) stake by 94% in Q1 2026, selling an estimated $1.94M and leaving 1,571 shares worth $115K. The position accounts for ﹤0.01% of the portfolio, ranked #4306.

BNP Paribas Financial Markets first reported a position in DRUG in Q1 2025 and has held it in 5 quarters since. The position peaked at $2M in Q4 2025. 94 funds tracked by Wall St. Rank hold DRUG as of Q1 2026.

  • BNP Paribas Financial Markets held 1,571 shares of Bright Minds Biosciences worth $115K as of Q1 2026.
  • BNP Paribas Financial Markets sold 24,105 Bright Minds Biosciences shares in Q1 2026, an estimated $1.94M.
  • Bright Minds Biosciences made up ﹤0.01% of BNP Paribas Financial Markets's portfolio in Q1 2026, its #4306 holding.
  • BNP Paribas Financial Markets first reported a position in Bright Minds Biosciences in Q1 2025 and has held it in 5 quarters since.
  • BNP Paribas Financial Markets's Bright Minds Biosciences position peaked at $2M in Q4 2025.
  • 94 funds tracked by Wall St. Rank held Bright Minds Biosciences as of Q1 2026.

Based on BNP Paribas Financial Markets's 13F filing for Q1 2026, filed 12 May 2026.